Tag Archives: Cardiovascular disease
By Ben Comer | Published: May 7, 2012
The news that Roche scrapped development on its CETP inhibitor dalcetrapib, a drug designed to raise HDL cholesterol in the blood, likely presages the shuttering of Lilly’s development program for its CETP inhibitor, evacetrapib, industry experts and analysts say.
By Sarah Houlton | Published: July 22, 2009
Image via Wikipedia Statins should be given to people with high blood pressure or diabetes, even if they donâ€™t have heart disease, according to a study published in the British Medical Journal. While several studies have shown that statins benefit those with cardiovascular disease, this is the first large study which looked at statins as […]